Literature DB >> 10741396

Binding of T lymphocytes to hippocampal neurons through ICAM-5 (telencephalin) and characterization of its interaction with the leukocyte integrin CD11a/CD18.

L Tian1, P Kilgannon, Y Yoshihara, K Mori, W M Gallatin, O Carpén, C G Gahmberg.   

Abstract

Intercellular adhesion molecule-5 (ICAM-5, telencephalin) is a member of the immunoglobulin superfamily expressed on telencephalic neurons, and serves as a ligand for the leukocyte integrin CD11 a/CD18. We studied here the binding site in ICAM-5 for CD11a/CD18. Protein constructs containing the first immunoglobulin domain of ICAM-5 were able to support CD11a/CD18 interaction, while deletion of the first domain abolished binding. Monoclonal antibodies reacting with the first domain of ICAM-5 also completely blocked the interaction. The soluble first domain of ICAM-5 inhibited the binding of T cells to immobilized ICAM-5 at concentrations of 50 nM and higher. Interestingly, the sixth domain of ICAM-5 was also able to support leukocyte binding, but this binding activity may not involve leukocyte integrins. To test the involvement of ICAM-5 in leukocyte-neuron interactions, an assay using human T cells binding to rat hippocampal neurons was established. This binding was blocked by monoclonal antibodies against CD11a/CD18 and ICAM-5. Thus ICAM-5 may act as a major adhesion molecule for leukocyte binding to neurons in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10741396     DOI: 10.1002/1521-4141(200003)30:3<810::AID-IMMU810>3.0.CO;2-X

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

1.  Clinical significance of co-expression of CD21 and LFA-1 in B-cell lymphoma.

Authors:  Kazushi Tanimoto; Yoshihiro Yakushijin; Hiroshi Fujiwara; Masaki Otsuka; Koichi Ohshima; Atsuro Sugita; Akira Sakai; Takaaki Hato; Hitoshi Hasegawa; Masaki Yasukawa
Journal:  Int J Hematol       Date:  2009-04-11       Impact factor: 2.490

2.  The second domain of intercellular adhesion molecule-1 (ICAM-1) maintains the structural integrity of the leucocyte function-associated antigen-1 (LFA-1) ligand-binding site in the first domain.

Authors:  P Stanley; A McDowall; P A Bates; J Brashaw; N Hogg
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

Review 3.  Leukocyte arrest: Biomechanics and molecular mechanisms of β2 integrin activation.

Authors:  Zhichao Fan; Klaus Ley
Journal:  Biorheology       Date:  2015       Impact factor: 1.875

4.  Interactions between ICAM-5 and β1 integrins regulate neuronal synapse formation.

Authors:  Lin Ning; Li Tian; Sergei Smirnov; Helena Vihinen; Olaya Llano; Kyle Vick; Ronald L Davis; Claudio Rivera; Carl G Gahmberg
Journal:  J Cell Sci       Date:  2012-09-26       Impact factor: 5.285

5.  Neuronal I kappa B kinase beta protects mice from autoimmune encephalomyelitis by mediating neuroprotective and immunosuppressive effects in the central nervous system.

Authors:  Mary Emmanouil; Era Taoufik; Vivian Tseveleki; Sotiris-Spyros Vamvakas; Theodore Tselios; Michael Karin; Hans Lassmann; Lesley Probert
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

Review 6.  Leukocyte integrins and their ligand interactions.

Authors:  Young-Min Hyun; Craig T Lefort; Minsoo Kim
Journal:  Immunol Res       Date:  2009-01-29       Impact factor: 2.829

Review 7.  Redox control of microglial function: molecular mechanisms and functional significance.

Authors:  Ana I Rojo; Gethin McBean; Marina Cindric; Javier Egea; Manuela G López; Patricia Rada; Neven Zarkovic; Antonio Cuadrado
Journal:  Antioxid Redox Signal       Date:  2014-05-05       Impact factor: 8.401

8.  ICAM-5 modulates cytokine/chemokine production in the CNS during the course of herpes simplex virus type 1 infection.

Authors:  Margaret C L Tse; Crystal Lane; Kevin Mott; Nattawat Onlamoon; Hui-Mien Hsiao; Guey Chuen Perng
Journal:  J Neuroimmunol       Date:  2009-07-09       Impact factor: 3.478

9.  Structural modifications of ICAM-1 cyclic peptides to improve the activity to inhibit heterotypic adhesion of T cells.

Authors:  Bimo A Tejo; Usman S F Tambunan; Gennady Verkhivker; Teruna J Siahaan
Journal:  Chem Biol Drug Des       Date:  2008-06-11       Impact factor: 2.817

10.  The TARC/sICAM5 Ratio in Patient Plasma is a Candidate Biomarker for Drug Resistant Epilepsy.

Authors:  John R Pollard; Ofer Eidelman; Gregory P Mueller; Clifton L Dalgard; Peter B Crino; Christopher T Anderson; Elizabeth J Brand; Evren Burakgazi; Sai K Ivaturi; Harvey B Pollard
Journal:  Front Neurol       Date:  2013-01-03       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.